comparemela.com

Jonathan Tunnicliffe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NovaQuest Capital Management Acquires TechAccels Interest In Covenant Animal Health Partners

NovaQuest Capital Management Acquires TechAccels Interest In Covenant Animal Health Partners
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

NovaQuest Capital Management: Argenta Enters $30 Million Product Financing Agreement with NovaQuest to Accelerate New Veterinary Product Development

(0) Argenta Limited ( Argenta ), the only global contract research organization (CRO) and contract development and manufacturing organization (CDMO) specializing in animal health, and NovaQuest Capital Management ( NovaQuest ) announced today a $30 million product financing agreement for the development of several innovative veterinary pharmaceuticals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210520005132/en/ The collaboration leverages NovaQuest s capital and expertise, and Argenta s knowledge and know-how in research and development activities that advance animal health. The capital investment from NovaQuest accelerates Argenta s strategy of providing innovative solutions and Molecule to Market services through global partnerships. We are delighted by the collaboration with NovaQuest and we look forward to strengthening our partnership through additional programs in the future, said Ben Russell, CEO of Arge

Argenta Enters $30 Million Product Financing Agreement with NovaQuest to Accelerate New Veterinary Product Development

Argenta Enters $30 Million Product Financing Agreement with NovaQuest to Accelerate New Veterinary Product Development on May 20 2021 8:30 PM RALEIGH, N.C. & AUCKLAND, New Zealand (BUSINESS WIRE) Argenta Limited (“Argenta”), the only global contract research organization (CRO) and contract development and manufacturing organization (CDMO) specializing in animal health, and NovaQuest Capital Management (“NovaQuest”) announced today a $30 million product financing agreement for the development of several innovative veterinary pharmaceuticals. The collaboration leverages NovaQuest’s capital and expertise, and Argenta’s knowledge and know-how in research and development activities that advance animal health. “The capital investment from NovaQuest accelerates Argenta’s strategy of providing innovative solutions and Molecule to Market services through global partnerships. We are delighted by the collaboration with NovaQuest and we look forward to strengthening our partn

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.